NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01245959,Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma,https://clinicaltrials.gov/study/NCT01245959,,UNKNOWN,"The purpose of this study is to compare induction chemotherapy (docetaxel+cisplatin+fluorouracil) plus concurrent chemoradiotherapy with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma (NPC), in order to confirm the value of induction chemotherapy in NPC patients.",NO,Nasopharyngeal Carcinoma,"DRUG: Docetaxel, cisplatin and fluorouracil|RADIATION: Concurrent chemoradiotherapy","Failure-free survival, Failure-free survival is calculated from the date of randomisation to the date of treatment failure or death from any cause, whichever is first., 3-year","Overall survival, Overall survival is calculated from randomization to death from any cause., 3-year|Locoregional failure-free survival, The latency (ie, time from randomisation) to the first locoregional failure, 3-year|Distant failure-free survival, The latency (ie, time from randomisation) to the first remote failure, 3-year|The initial response rates after treatments, A week after completion of the last cycle of induction chemotherapy and 16 weeks after completion of radiotherapy|Toxic effects, During and after treatment",,Sun Yat-sen University,Fudan University|West China Hospital|Huazhong University of Science and Technology|Peking University Cancer Hospital & Institute|Zhejiang Cancer Hospital|Central South University|Jiangsu Cancer Institute & Hospital|First People's Hospital of Foshan|The Third Affiliated Hospital of Harbin Medical University|Cancer Hospital of Guangxi Medical University|Jiangxi Provincial Cancer Hospital|Guangzhou Medical University,ALL,ADULT,PHASE3,476,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,YP2010171,2011-01,2016-04,2018-04,2010-11-23,,2014-02-13,"Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China",
